297 related articles for article (PubMed ID: 26353844)
1. Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?
Kleczkowska P; Smaga I; Filip M; Bujalska-Zadrozny M
Neurotox Res; 2016 Jan; 29(1):173-96. PubMed ID: 26353844
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
3. The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?
Oppong-Damoah A; Gannon BM; Murnane KS
CNS Neurol Disord Drug Targets; 2022; 21(1):3-13. PubMed ID: 33573565
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.
Svízenská I; Dubový P; Sulcová A
Pharmacol Biochem Behav; 2008 Oct; 90(4):501-11. PubMed ID: 18584858
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
De Luca MA; Fattore L
Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
[TBL] [Abstract][Full Text] [Related]
6. CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications.
Jagerovic N; Fernandez-Fernandez C; Goya P
Curr Top Med Chem; 2008; 8(3):205-30. PubMed ID: 18289089
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
González S; Cebeira M; Fernández-Ruiz J
Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
[TBL] [Abstract][Full Text] [Related]
8. PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models.
Alen F; Decara J; Brunori G; You ZB; Bühler KM; López-Moreno JA; Cippitelli A; Pavon FJ; Suárez J; Gardner EL; de la Torre R; Ciccocioppo R; Serrano A; Rodríguez de Fonseca F
Biochem Pharmacol; 2018 Nov; 157():235-243. PubMed ID: 30195735
[TBL] [Abstract][Full Text] [Related]
9. A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.
Pava MJ; Woodward JJ
Alcohol; 2012 May; 46(3):185-204. PubMed ID: 22459871
[TBL] [Abstract][Full Text] [Related]
10. Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.
Greineisen WE; Turner H
Int Immunopharmacol; 2010 May; 10(5):547-55. PubMed ID: 20219697
[TBL] [Abstract][Full Text] [Related]
11. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
Ashton JC; Milligan ED
Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use.
Chang CE; Ai R; Gutierrez M; Marsella MJ
Methods Mol Biol; 2012; 819():595-613. PubMed ID: 22183560
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the endocannabinoid system in osteoarthritis pain.
La Porta C; Bura SA; Negrete R; Maldonado R
Eur J Neurosci; 2014 Feb; 39(3):485-500. PubMed ID: 24494687
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
Mendizábal VE; Adler-Graschinsky E
Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of cannabinoid-based drugs.
Klein TW; Newton CA
Adv Exp Med Biol; 2007; 601():395-413. PubMed ID: 17713029
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of cannabinoid receptor ligands: current status.
Singh J; Budhiraja S
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
[TBL] [Abstract][Full Text] [Related]
19. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
Hungund BL; Basavarajappa BS
Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
Burns TL; Ineck JR
Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
